Stem cell therapy for Parkinson’s disease reaches milestone

The first of a total of eight patients with Parkinson’s disease has now received a stem cell transplant in the phase I/II STEM-PD clinical study. The treatment involves transplanting patients with new dopamine-producing stem cells to replace cells destroyed by the disease.

Read the article at biostock.se:

https://www.biostock.se/en/2023/03/stem-cell-therapy-for-parkinsons-disease-reaches-milestone/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/